These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 3907362)

  • 1. Leu-M1 antigen expression in T-cell neoplasia.
    Wieczorek R; Burke JS; Knowles DM
    Am J Pathol; 1985 Dec; 121(3):374-80. PubMed ID: 3907362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues.
    Pinkus GS; Thomas P; Said JW
    Am J Pathol; 1985 May; 119(2):244-52. PubMed ID: 3887932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leu-M1 antigen expression in advanced (tumor) stage mycosis fungoides.
    Wieczorek R; Suhrland M; Ramsay D; Reed ML; Knowles DM
    Am J Clin Pathol; 1986 Jul; 86(1):25-32. PubMed ID: 3088980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies in the diagnosis of Hodgkin's disease. The search for a rational panel.
    Chittal SM; Caverivière P; Schwarting R; Gerdes J; Al Saati T; Rigal-Huguet F; Stein H; Delsol G
    Am J Surg Pathol; 1988 Jan; 12(1):9-21. PubMed ID: 2827535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The spectrum of Leu-M1 staining in lymphoid and hematopoietic proliferations.
    Swerdlow SH; Wright SA
    Am J Clin Pathol; 1986 Mar; 85(3):283-8. PubMed ID: 2428238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte and HLA-D region specific monoclonal antibodies in the diagnosis of Hodgkin's disease.
    Norton AJ; Isaacson PG
    J Clin Pathol; 1985 Nov; 38(11):1241-6. PubMed ID: 3864794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies reactive in routinely processed tissue sections of malignant lymphoma, with emphasis on T-cell lymphomas.
    Strickler JG; Weiss LM; Copenhaver CM; Bindl J; McDaid R; Buck D; Warnke R
    Hum Pathol; 1987 Aug; 18(8):808-14. PubMed ID: 3301626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bauhinia purpurea--a new paraffin section marker for Reed-Sternberg cells of Hodgkin's disease. A comparison with Leu-M1 (CD15), LN2 (CD74), peanut agglutinin, and Ber-H2 (CD30).
    Sarker AB; Akagi T; Jeon HJ; Miyake K; Murakami I; Yoshino T; Takahashi K; Nose S
    Am J Pathol; 1992 Jul; 141(1):19-23. PubMed ID: 1352944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of combining antigranulocyte with antileukocyte antibodies in differentiating Hodgkin's disease from non-Hodgkin's lymphoma.
    Medeiros LJ; Weiss LM; Warnke RA; Dorfman RF
    Cancer; 1988 Dec; 62(12):2475-81. PubMed ID: 2973368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopathology of cutaneous T-cell lymphomas.
    Nasu K; Said J; Vonderheid E; Olerud J; Sako D; Kadin M
    Am J Pathol; 1985 Jun; 119(3):436-47. PubMed ID: 3893149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leu M1 and S100 in Hodgkin's disease and non-Hodgkin's lymphomas.
    Kornstein MJ; Bonner H; Gee B; Cohen R; Brooks JJ
    Am J Clin Pathol; 1986 Apr; 85(4):433-7. PubMed ID: 3754087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of Leu M1 monoclonal antibody in the differential diagnosis of Hodgkin's disease.
    Hyder DM; Schnitzer B
    Arch Pathol Lab Med; 1986 May; 110(5):416-9. PubMed ID: 3516118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexisting Hodgkin's disease and mycosis fungoides. Immunohistochemical proof of its existence.
    Simrell CR; Boccia RV; Longo DL; Jaffe ES
    Arch Pathol Lab Med; 1986 Nov; 110(11):1029-34. PubMed ID: 3096258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody Leu-22 (L60) permits the demonstration of some neoplastic T cells in routinely fixed and paraffin-embedded tissue sections.
    Wieczorek R; Buck D; Bindl J; Knowles DM
    Hum Pathol; 1988 Dec; 19(12):1434-43. PubMed ID: 2973429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leu M-1 antigen: comparative expression in Hodgkin's disease and T cell lymphoma.
    Strauchen JA; Breakstone B
    Hematol Oncol; 1987; 5(2):107-14. PubMed ID: 2885252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of anti-Leu-M1 as a marker in Hodgkin's disease.
    Frierson HF; Innes DJ
    Arch Pathol Lab Med; 1985 Nov; 109(11):1024-8. PubMed ID: 3840354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of a Hodgkin and Reed-Sternberg cell associated antigen (Ki-1) in cutaneous lymphoid infiltrates.
    Ralfkiaer E; Bosq J; Gatter KC; Schwarting R; Gerdes J; Stein H; Mason DY
    Arch Dermatol Res; 1987; 279(5):285-92. PubMed ID: 2820316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoblastic lymphoma: an immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia.
    Weiss LM; Bindl JM; Picozzi VJ; Link MP; Warnke RA
    Blood; 1986 Feb; 67(2):474-8. PubMed ID: 3080041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
    Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
    Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leu-22: a preferential marker for T-lymphocytes in paraffin sections. Staining profile in T- and B-cell lymphomas, Hodgkin's disease, other lymphoproliferative disorders, myeloproliferative diseases, and various neoplastic processes.
    Said JW; Stoll PN; Shintaku P; Bindl JM; Butmarc JR; Pinkus GS
    Am J Clin Pathol; 1989 May; 91(5):542-9. PubMed ID: 2785753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.